18 The prescribing information for oral semaglutide notes that the most common side effects with use include nausea, abdominal pain, diarrhea, decreased appetite, vomiting, and constipation
A new paradigm for treating to target with second-generation obesity medications
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral
A BMI of 27 or above indicates obesity, and at least one weight-related medical condition (such as type 2 diabetes or high blood pressure) must exist
Obesity care clinicians provide personalized support from initial assessment to continuous care, including prescribing medications based on individual needs of each patient
Pharmacies are having trouble keeping them in stock and patients are complaining that they cant get them